A chaperone-dependent GSK3β transitional intermediate mediates activation-loop autophosphorylation

被引:229
作者
Lochhead, Pamela A.
Kinstrie, Ross
Sibbet, Gary
Rawjee, Teeara
Morrice, Nick
Cleghon, Vaughn
机构
[1] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland
[2] Univ Dundee, Sch Life Sci, MRC, Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland
关键词
D O I
10.1016/j.molcel.2006.10.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Glycogen synthase kinase 3 (GSK3), a key component of the insulin and wnt signaling pathways, is unusual, as it is constitutively active and is inhibited in response to upstream signals. Kinase activity is thought to be increased by intramolecular phosphorylation of a tyrosine in the activation loop (Y216 in GSK3 beta), whose timing and mechanism is undefined. We show that GSK3 beta autophosphorylates Y216 as a chaperone-dependent transitional intermediate possessing intramolecular tyrosine kinase activity and displaying different sensitivity to small-molecule inhibitors compared to mature GSK3 beta. After autophosphorylation, mature GSK3 beta is then an intermolecular serine/threonine kinase no longer requiring a chaperone. This shows that autoactivating kinases have adopted different molecular mechanisms for autophosphorylation; and for kinases such as GSK3, inhibitors that affect only the transitional intermediate would be missed in conventional drug screens.
引用
收藏
页码:627 / 633
页数:7
相关论文
共 33 条
[11]  
FIOL CJ, 1987, J BIOL CHEM, V262, P14042
[12]   GSK3 takes centre stage more than 20 years after its discovery [J].
Frame, S ;
Cohen, P .
BIOCHEMICAL JOURNAL, 2001, 359 (01) :1-16
[13]   Expression and characterization of GSK-3 mutants and their effect on β-catenin phosphorylation in intact cells [J].
Hagen, T ;
Di Daniel, E ;
Culbert, AA ;
Reith, AD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (26) :23330-23335
[14]   MODULATION OF THE GLYCOGEN-SYNTHASE KINASE-3 FAMILY BY TYROSINE PHOSPHORYLATION [J].
HUGHES, K ;
NIKOLAKAKI, E ;
PLYTE, SE ;
TOTTY, NF ;
WOODGETT, JR .
EMBO JOURNAL, 1993, 12 (02) :803-808
[15]   The glamour and gloom of glycogen synthase kinase-3 [J].
Jope, RS ;
Johnson, GVW .
TRENDS IN BIOCHEMICAL SCIENCES, 2004, 29 (02) :95-102
[16]   The novel tyrosine kinase ZAK1 activates GSK3 to direct cell fate specification [J].
Kim, L ;
Liu, JC ;
Kimmel, AR .
CELL, 1999, 99 (04) :399-408
[17]   GSK3, a master switch regulating cell-fate specification and tumorigenesis [J].
Kim, L ;
Kimmel, AR .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2000, 10 (05) :508-514
[18]   1-azakenpaullone is a selective inhibitor of glycogen synthase kinase-3β [J].
Kunick, C ;
Lauenroth, K ;
Leost, M ;
Meijer, L ;
Lemcke, T .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (02) :413-416
[19]   Activation-loop autophosphorylation is mediated by a novel transitional intermediate form of DYRKs [J].
Lochhead, PA ;
Sibbet, G ;
Morrice, N ;
Cleghon, V .
CELL, 2005, 121 (06) :925-936
[20]   Inhibition of GSK-3 selectively reduces glucose-B-phosphatase and phosphoenolpyruvate carboxykinase gene expression [J].
Lochhead, PA ;
Coghlan, M ;
Rice, SQJ ;
Sutherland, C .
DIABETES, 2001, 50 (05) :937-946